White Lab Genomics

May 23, 2025

WhiteLab Genomics develops and leverages its proprietary AI platform to accelerate and optimize genomic medicine research and development (gene, cell, and RNA therapies). The company has created a proprietary atlas of cellular biomarkers and uses AI for target identification and vector design (viral and non-viral/nanoparticle), as well as for payload design and bioproduction optimization. We boast a robust portfolio of collaborations with academia, biotechs, and pharmaceutical leaders such as Sanofi. We are a Y Combinator and VC-backed company, with offices in Paris, France; Boston, USA; and Montreal, Canada.

Industry news

June 18, 2025

Médicament Québec Awards Two Major Grants for RNA Innovation with Financial Support from the Ministère de l’Économie, de l’Innovation et de l’Énergie (MEIE)

Learn more

June 17, 2025

MedicalExpo E-Magazine article highlights AReNA’s panelists at 2025 EFFERVESCENCE on RNA Therapies: From Pandemic Vaccines to Tomorrow’s Medicine.

Learn more

May 8, 2025

The creation of a biomanufacturing services platform to boost expertise in Quebec and accelerate the development of RNA therapies

Learn more

June 6, 2024

White Lab Genomics

Industry news

Médicament Québec Awards Two Major Grants for RNA Innovation with Financial Support from the Ministère de l’Économie, de l’Innovation et de l’Énergie (MEIE)

AReNA shines at BIO 2025

Eli Lilly and Company to Acquire Verve Therapeutics for Up to $1.3 Billion

AReNA sponsors Rendez-vous Québec at the launch of the BIO International Convention

Pharmaceutiques Magazine spotlights Quebec, driving force for North America’s RNA Sector

DirectIndustry’s take on AReNA, Quebec’s Ambitious Plan to Become a Global RNA Therapeutics Leader

MedicalExpo E-Magazine article highlights AReNA’s panelists at 2025 EFFERVESCENCE on RNA Therapies: From Pandemic Vaccines to Tomorrow’s Medicine.

D2R et AReNA put RNA experts forward at the 92nd ACFAS Congress

AReNA’s expert panel and networking breakfast energize EFFERVESCENCE conference in Montreal

Panagiotis Prinos appointed as Director of Réseau DePTAQ

The AReNA breakfast series presents the CELLULE and the RNA valorisation and entrepreneurship team.

CASTL and the DePTAQ Network present their initiative during AReNA’s breakfast event at IRCM

Jean-Pierre Perreault is elected as Rector of Université de Sherbrooke

Two panelists represent AReNA at Leyton Connect’s 5-to-7

AReNA attended FISQ

AReNA attends CASTL’s Open Door Day

Epitopea closes their $31 million pre-Series A financing.

Congratulations to the Nobel Prize winners in Medicine!

Congratulations to the 23 recipients of the D2R funding programs

The creation of training programs to meet the needs of the RNA therapeutics industry

The creation of a biomanufacturing services platform to boost expertise in Quebec and accelerate the development of RNA therapies

A new initiative to stimulate innovation and entrepreneurship in the RNA therapy sector in Quebec

Quebec Launches AReNA to Become a Global Leader in RNA Therapies

A group of partners are launching the CELLULE to accelerate the development of RNA therapies in Quebec

The long-overlooked molecule that will define a generation of science

White Lab Genomics

Industry news

Médicament Québec Awards Two Major Grants for RNA Innovation with Financial Support from the Ministère de l’Économie, de l’Innovation et de l’Énergie (MEIE)

AReNA shines at BIO 2025

Eli Lilly and Company to Acquire Verve Therapeutics for Up to $1.3 Billion

AReNA sponsors Rendez-vous Québec at the launch of the BIO International Convention

Pharmaceutiques Magazine spotlights Quebec, driving force for North America’s RNA Sector

DirectIndustry’s take on AReNA, Quebec’s Ambitious Plan to Become a Global RNA Therapeutics Leader

MedicalExpo E-Magazine article highlights AReNA’s panelists at 2025 EFFERVESCENCE on RNA Therapies: From Pandemic Vaccines to Tomorrow’s Medicine.

D2R et AReNA put RNA experts forward at the 92nd ACFAS Congress

AReNA’s expert panel and networking breakfast energize EFFERVESCENCE conference in Montreal

Panagiotis Prinos appointed as Director of Réseau DePTAQ

The AReNA breakfast series presents the CELLULE and the RNA valorisation and entrepreneurship team.

CASTL and the DePTAQ Network present their initiative during AReNA’s breakfast event at IRCM

Jean-Pierre Perreault is elected as Rector of Université de Sherbrooke

Two panelists represent AReNA at Leyton Connect’s 5-to-7

AReNA attended FISQ

AReNA attends CASTL’s Open Door Day

Epitopea closes their $31 million pre-Series A financing.

Congratulations to the Nobel Prize winners in Medicine!

Congratulations to the 23 recipients of the D2R funding programs

The creation of training programs to meet the needs of the RNA therapeutics industry

The creation of a biomanufacturing services platform to boost expertise in Quebec and accelerate the development of RNA therapies

A new initiative to stimulate innovation and entrepreneurship in the RNA therapy sector in Quebec

Quebec Launches AReNA to Become a Global Leader in RNA Therapies

A group of partners are launching the CELLULE to accelerate the development of RNA therapies in Quebec

The long-overlooked molecule that will define a generation of science

Stay up to date with the latest news on RNA therapies